International audienceInvestigation of existing drugs is an effective alternative to the discovery of new drugs for treating diseases. This task of drug re-positioning can be assisted by various kinds of computational methods to predict the best indication for a drug given the open-source biological datasets. Owing to the fact that similar drugs tend to have common pathways and disease indications, the association matrix is assumed to be of low-rank structure. Hence, the problem of drug-disease association prediction can be modeled as a low-rank matrix completion problem. In this work, we propose a novel matrix completion framework that makes use of the side-information associated with drugs/diseases for the prediction of drug-disease indic...
Drug discovery is an expensive and labor-intensive process, typically taking an average of 10–15 yea...
Motivation: Computational drug repositioning is a cost-effective strategy to identify novel indicati...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
International audienceInvestigation of existing drugs is an effective alternative to the discovery o...
Identification of potential drug-associated indications is critical for either approved or novel dru...
Overview This repository contains data and code for HGIMC method, which is based on the model at ht...
Abstract Background Drug-disease associations provide important information for the drug discovery. ...
Abstract Background Identifying drug–target interactions (DTIs) plays a key role in drug development...
Abstract Background Disease-drug associations provide essential information for drug discovery and d...
Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical compan...
The identification of potential interactions between drugs and target proteins is crucial in pharmac...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Identification of potential drug-associated indications is critical for either approved or novel dru...
Abstract Background Because drug–drug interactions (DDIs) may cause adverse drug reactions or contri...
Abstract Background Identifying drug–target interactions (DTIs) plays a key role in drug development...
Drug discovery is an expensive and labor-intensive process, typically taking an average of 10–15 yea...
Motivation: Computational drug repositioning is a cost-effective strategy to identify novel indicati...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
International audienceInvestigation of existing drugs is an effective alternative to the discovery o...
Identification of potential drug-associated indications is critical for either approved or novel dru...
Overview This repository contains data and code for HGIMC method, which is based on the model at ht...
Abstract Background Drug-disease associations provide important information for the drug discovery. ...
Abstract Background Identifying drug–target interactions (DTIs) plays a key role in drug development...
Abstract Background Disease-drug associations provide essential information for drug discovery and d...
Mining potential drug-disease associations can speed up drug repositioning for pharmaceutical compan...
The identification of potential interactions between drugs and target proteins is crucial in pharmac...
The growing number and variety of genetic network datasets increases the feasibility of understandin...
Identification of potential drug-associated indications is critical for either approved or novel dru...
Abstract Background Because drug–drug interactions (DDIs) may cause adverse drug reactions or contri...
Abstract Background Identifying drug–target interactions (DTIs) plays a key role in drug development...
Drug discovery is an expensive and labor-intensive process, typically taking an average of 10–15 yea...
Motivation: Computational drug repositioning is a cost-effective strategy to identify novel indicati...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...